| Literature DB >> 35022061 |
José María Pego-Reigosa1,2, Carlos Peña-Gil3,4, David Rodríguez-Lorenzo5, Irene Altabás-González6,7, Naír Pérez-Gómez6,7, John Henry Guzmán-Castro6, Rodrigo Varela-Gestoso8, Reyes Díaz-Lambarri9, Alberto González-Carreró-López10, Olga Míguez-Senra10, Julia Bóveda-Fontán11, Ángeles Charle-Crespo12, Francisco Javier Caramés-Casal13, Ceferino Barbazán-Álvarez6, Íñigo Hernández-Rodríguez6, Francisco Maceiras-Pan6,7, Marina Rodríguez-López6, Rafael Melero-González6,7, José Benito Rodríguez-Fernández14.
Abstract
OBJECTIVE: To describe in detail an innovative program based on telemedicine for semi-automated prioritization of referrals from Primary Care (PC) to Rheumatology, for reproducibility purposes, and to present the results of the implementation study.Entities:
Keywords: Early diagnosis; Implementation; Medical informatics; Needs assessment; Rheumatic diseases; Telemedicine
Mesh:
Year: 2022 PMID: 35022061 PMCID: PMC8754366 DOI: 10.1186/s12913-021-07455-4
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1Process before the implementation of the innovative IT solution: original referral circuit and consultations from Primary Care to Rheumatology. PCP: Primary Care Physician; PE: physical exam; IANUS: electronic health record system in Galicia; PC: Primary care. The patient is referred to Rheumatology without a prioritization or without further request of tests. When seen (face-to-face) in Rheumatology, the patient is completely unknown to the rheumatologist
Indicators and results of the program from October 2014 to June 2017
| Objectivea | Indicator | Result |
|---|---|---|
| To establish a tool for the integration of care between PC and Rheumatology | Ratio of referrals from PC channeled through the new electronic system | 100% of 6185 |
| To establish a process for managing Rheumatology e-consultations from PC | Implemented process for managing the e-consultations received | In full |
| To identify patients referred from PC who should be attended preferentially by Rheumatology (prioritization) | Waiting days for priority pathologies (recent onset arthritis, suspected connective disease, etc.) | 8.95 days (Previously 83.1 days) |
| To improve the performance of essential diagnostic tests | % of patients assessed face-to-face with the essential diagnostic tests already available | 89%a (Previously 68%)a aFrom random samples 2 months |
| To reduce waiting time of PC referrals to Rheumatology | Waiting days for all referrals (face-to-face and e-consultation) | 12.6 days (Previously 83.1 days) |
| Virtual resolution of e-consultations from PC to Rheumatology. | n (%) of e-consultations that are resolved virtually | 1195 visits (20%) |
| To improve the resolution of the first face-to-face consultation | n (%) of first face-to-face consultations that are resolved in a single act | 1369 (32.3%) of 4240 patients seen after e-consultation |
| To reduce Rheumatology waiting time of patients referred from other specialties | Waiting days of patients referred from other hospital specialties to specialized rheumatological care | 19.2 days (Previously 83.1) |
a For first referrals (e-consultations) from PC to Rheumatology service (n = 6185)
Fig. 2Process after the implementation of the innovative IT solution. The program: referral circuit, IT systems, and consultations in Rheumatology of patients referred from Primary Care. PCP: Primary Care Physician; PE: physical exam; IANUS: electronic health record system in Galicia. The patient is referred to Rheumatology, previous request of additional tests already agreed upon between PC and Rheumatology. The case is electronically seen by the Rheumatologist in the 2.T.0 Agenda, where he or she can add further tests or solve the case without a face-to-face visit. A second prioritization occurs here before the first face-to-face visit in Rheumatology (2.T.1 Agenda)
Fig. 3Referral screen (adapted for comprehension). F: female; M: male; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; RF: rheumatoid factor; ACPA: anti-citrullinated peptide antibodies; MSK: musculoskeletal; ANA: anti-nuclear antibodies; IBD: inflammatory bowel disease